Stockreport

Histogen to Present at the HC Wainwright 22nd Annual Global Investment Conference

Histogen Inc.  (HSTO) 
PDF SAN DIEGO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restor [Read more]